Your browser does not support JavaScript or it may be disabled!
rediff.com
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
NEWS ON MOBILE
Get Realtime News
on your webpage

About 273 results for "Byetta"

Byetta Lawsuit News: New Order Issued in Federal Incretin Mimetics...
PRWeb

Byetta Lawsuit News: New Order Issued in Federal Incretin Mime...

The Firm is evaluating Byetta lawsuits on behalf of individuals who developed pancreatitis, pancreatic cancer or thyroid cancer allegedly due to their use of Byetta or other incretin mimetic Type 2 diabetes drug. Byetta lawsuits ... PRWeb, 1 week ago
[x]  

1 images for "Byetta"

PRWeb, 1 week ago

Human medicines European public assessment report (EPAR): Byetta, exenatide, Revision: 14, Authorised

This is a summary of the European public assessment report (EPAR) for Byetta. It explains how the Committee for Medicinal Products for Human Use (CHMP) assessed the medicine to reach its opinion in favour of granting a marketing authorisation and ...
 European Medicines Agency3 weeks ago
PRWeb

Byetta Lawsuits Move Forward, as Bernstein Liebhard LLP Notes Settlements in More than 80 Cases

Hundreds of Byetta lawsuits (http://www.byettalawsuit.com) and other incretin mimetic claims continue to move forward in U.S. courts, Bernstein Liebhard LLP reports. According to a statement issued by AstraZeneca PLC on July 31, 2014, Byetta and ...
 Digital Journal3 weeks ago Byetta Lawsuit News: Bernstein Liebhard LLP Notes British Columbia's Recent Decision to Discontinue Incretin Mimetic Drug Coverage from PharmaCare Program  Digital Journal1 month ago
[x]  

Eli Lilly receives FDA approval for treatment option of type 2 diabetes

Eli Lilly and Company has received the FDA approval for Trulicity as a treatment option for adults with type 2 diabetes. Trulicity is indicated as an adjunct to diet and exercise to improve glycemic control in adults with type 2 diabetes. Trulicity ...
 Individual.com11 hours ago Eli Lilly's Trulicity receives US FDA approval to treat adults with type 2 diabetes  PharmaBiz3 days ago Eli Lilly's Trulicity Approved by FDA for Type II Diabetes  Yahoo! Finance4 days ago FDA approves new Lilly type 2 diabetes therapeutic  Drug Discovery News4 days ago
[x]  

AstraZeneca reports positive results from Phase III trial of exenatide in type 2 diabetes

British drug-maker AstraZeneca has reported positive results from a 28-week Phase III trial of exenatide to treat adult patients with type 2 diabetes. The trial called DURATION-NEO-1 compared an investigational formulation of exenatide once-weekly ...
 Pharmaceutical Business Review1 day ago ASTRAZENECA : Study showed AstraZeneca's exenatide once-weekly suspension for autoinjection provided superior HbA1c reductions vs. twice-daily exenatide (Byetta®) in adults with type 2 diabetes  4 Traders4 days ago

AstraZeneca : Bydureon Pen Available in U.S.

AstraZeneca reported that once-weekly Bydureon (exenatide extended-release for injectable suspension) Pen 2 mg, a prescription medicine, is now available in pharmacies across the United States . According to a release from the company, Bydureon ...
 4 Traders3 days ago BYDUREON® Pen, a Treatment Option for Adults with Type 2 Diabetes, Now Available in Pharmacies  4 Traders6 days ago AstraZeneca: Bydureon Pen Available in U.S.  Individual.com1 week ago BYDUREON Pen, a Treatment Option for Adults with Type 2 Diabetes, Now Available in Pharmacies  Pharmaceutical & Medical Packaging News2 weeks ago
[x]  

Novo finds new way to sell Tresiba in EU while awaiting another shot in U.S.

Xultophy is a combo of Tresiba and Victoza Share Tools Novo Nordisk ($NVO) is hustling to get work done so that it can resubmit its blockbuster hopeful Tresiba to the FDA next year with an eye on getting into the market by 2016, three years ...
 FiercePharma4 days ago

Lilly Says FDA Approves Type 2 Diabetes Drug Trulicity

Drugmaker Eli Lilly and Co. (LLY: Quote) announced Thursday that the U.S. Food and Drug Administration has approved Trulicity (dulaglutide) as the latest treatment option for adults with type 2 diabetes. Trulicity is not insulin, but acts like ...
 RTTNews.com4 days ago 9/19/14 - Lilly Says FDA Approves Type 2 Diabetes Drug Trulicity  Pharmacy Choice4 days ago

America's Got Talent Finale: Quintavious Johnson Should Win It All

Season 9 of America's Got Talent will crown it's winner on Sept. 17, and with six acts remaining, the finale is definitely going to be intense! Every act is amazing, but 12-year-old singer, Quintavious Johnson is the total package and deserves to ...
 Mail.com6 days ago

Global Diabetes Market Trends & Future Forecast

• Global Diabetes Drug, Insulin, DPP-IV, GLP-1 Agonists Market and Future Forecast • Region wise Diabetes, Impaired Glucose Tolerance (IGT) Population and Prevalence • Region wise Diabetes Health Expenditure and Mortality • Top 10 ...
 Computeruser.com1 week ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
1.
2.
3.
4.
5.
6.
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts

Get

Realtime News

on your Webpage

Add Widget >Get your members hooked!
    
Alerts
Get updated on latest news & your favorite topics right in your inbox!
 
More     Less